Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin‐induced mouse model of asthma

Tomomi Ichikawa, Ryuji Hayashi, Kensuke Suzuki, +14

Respirology

Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study

Kensuke Suzuki, Hideaki Furuse, Takeshi Tsuda, +10

Journal of International Medical Research

Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor

Minehiko Inomata, Tomonobu Kado, Seisuke Okazawa, +11

Anticancer Research

SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients

Chihiro Taka, Ryuji Hayashi, Kazuki Shimokawa, +7

International Journal of COPD

Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case report

Minehiko Inomata, Ryuji Hayashi, Kenta Kambara, +10

Journal of Medical Case Reports

Neuro-oncologyTumoral PathologyHealth SciencesMedicineMultiple Pulmonary Nodule +13

Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib

Minehiko Inomata, Ryuji Hayashi, Hiroaki Tanaka, +11

Molecular and Clinical Oncology

Visceral adipose tissue level, as estimated by the bioimpedance analysis method, is associated with impaired lung function

Minehiko Inomata, Yukio Kawagishi, Chihiro Taka, +14

Journal of Diabetes Investigation

Lactate Dehydrogenase and Body Mass Index are Prognostic Factors in Patients with Recurrent Small Cell Lung Cancer Receiving Amrubicin

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, +9

Tumori Journal

Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy

Minehiko Inomata, Takahiro Hirai, Zenta Seto, +10

Pathology & Oncology Research

OncologyNovel TherapyPharmacologyImmune Checkpoint InhibitorPharmacotherapy +3

Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer

Minehiko Inomata, Masahiro Matsumoto, Naoki Takata, +12

Scientific Reports